Effects of azithromycin in Pseudomonas aeruginosa burn wound infection. 2013

David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
Pulmonary Medicine Division, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA. nicholsd@njhealth.org

BACKGROUND Cutaneous thermal injuries (i.e., burns) remain a common form of debilitating trauma, and outcomes are often worsened by wound infection with environmental bacteria, chiefly Pseudomonas aeruginosa. METHODS We tested the effects of early administration of a single dose of azithromycin, with or without subsequent antipseudomonal antibiotics, in a mouse model of standardized thermal injury infected with P aeruginosa via both wound site and systemic infection. We also tested the antimicrobial effects of these antibiotics alone or combined in comparative biofilm and planktonic cultures in vitro. RESULTS In our model, early azithromycin administration significantly reduced wound and systemic infection without altering wound site or circulating neutrophil activity. The antimicrobial effect of azithromycin was additive with ciprofloxacin but significantly reduced the antimicrobial effect of tobramycin. This pattern was reproduced in biofilm cultures and not observed in planktonic cultures of P aeruginosa. CONCLUSIONS These data suggest that early administration of azithromycin following burn-related trauma and infection may reduce P aeruginosa infection and potential interactions with other antibiotics should be considered when designing future studies.

UI MeSH Term Description Entries
D008297 Male Males
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
March 1988, Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
February 2020, Burns : journal of the International Society for Burn Injuries,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
May 2013, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
October 2013, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
August 2004, Antimicrobial agents and chemotherapy,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
June 2007, Antimicrobial agents and chemotherapy,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
December 2021, Drug delivery,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
July 2014, PLoS genetics,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
August 1979, Khirurgiia,
David P Nichols, and Silvia Caceres, and Lindsay Caverly, and Cori Fratelli, and Sun Ho Kim, and Ken Malcolm, and Katie R Poch, and Milene Saavedra, and George Solomon, and Jennifer Taylor-Cousar, and Samuel Moskowitz, and Jerry A Nick
February 2021, Burns : journal of the International Society for Burn Injuries,
Copied contents to your clipboard!